By combining personal branding with high standards, the company hopes to bring more awareness to the category by helping consumers make more informed choices.
Williams and his business partner, Jay Campbell, started out as influencers in the biohacking space and quickly realized the opportunity for non-injectable delivery systems to make peptides accessible to a wider range of consumers.
While BioLongevity Labs does offer oral capsules, it recently launched oral peptide lozenges, which Williams describes as similar to the format of Listerine strips. He explained that the lozenges bypass digestion for systemic absorption, offering benefits close to injections.
“Not to go into a whole chemistry lesson, but basically peptides are fragile molecules and so when you ingest them orally, depending on the peptide, they can be broken down by the digestive tract, and you don’t get systemic absorption because it’s broken up in digestion,” he said.
“So what’s cool about the strips is that it actually is absorbed through the buccal membrane in the mouth and it’s able to go systemic in the bloodstream that way. You actually get almost as close to the efficacy of an injectable peptide through that absorption mechanism. There’s a ton of different crazy biotech stuff that I’m not smart enough to talk about that they have to do to develop those, but it’s pretty cool because now people can experience some of the benefits of popular peptides like BPC -157 or GHK-cu literally with just using an oral strip instead of having to inject themselves.”
With a rich history in Russia, it appears bioregulators are making their way into the United States. A major goal of BioLongevity Labs is to establish trust and transparency in the U.S. market, driven by a mission to help others and challenge the status quo in peptide delivery. Williams explained that everything that BioLongevity Labs sells gets tested by a third-party lab and is published on the company site.
“A lot of companies, they’re doing it right—they’re selling for research purposes only,” he said. “Where I think there’s a gap in the marketplace is that even with third-party testing being done, a lot of people don’t have the tools and background to even understand what a third-party test looks like.
“One of the most-asked questions I get from people in my readership and audience all the time is, ‘It’s great that you have COAs [Certificate of Analysis] on the website that show the purity, but I don’t really know what I’m looking at.’”
That’s where Williams said the education aspect comes in.
“What we’ve done a really good job doing is giving people long-form content to where by the time they’ve listened to 7 to 10 hours of information about peptides, they actually are ready to do something that they may have been uncomfortable with, which is try a new product,” he said. “So that’s kind of been our strategy. It takes a lot more work on our end to do so, but I think it goes above and beyond building trust with the audience in a way that a lot of brands don’t really focus on.”
“I’m really of the mindset that the more people that get exposure to peptides, whether it’s from our company or not, it’s a win-win because we end up transforming the health of the world in doing so,” he added.
To hear more peptides and healthy aging including the benefits and science, along with building a domestic supply chain and the regulatory landscape, listen to the NutraCast.
If you enjoy listening to the NutraCast, feel free to leave a review. You can subscribe on Apple, iHeart, Spotify or wherever you get your podcasts.
